Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.33 |
| ▸ | JAK3 | P52333 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.31 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.30 |
| ▸ | CTSA | P10619 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23968999 | 0.92 | KDM4E (0.33) | KDM4EMAPTL3MBTL1 | |
| SCHEMBL21917696 | 0.92 | RXRA (0.37) | KDM4EMAPTL3MBTL1RPS6KA3JAK3 | |
| SCHEMBL23968819 | 0.88 | BACE1 (0.41) | KDM4EMAPTL3MBTL1AKR1C3AKR1C2 | |
| SCHEMBL23969088 | 0.87 | KDM4E (0.46) | KDM4EMAPTL3MBTL1AKR1C3AKR1C2 | |
| SCHEMBL23969000 | 0.86 | RXRA (0.45) | KDM4EMAPTL3MBTL1PTGDR2 | |
| SCHEMBL21917695 | 0.84 | — | — | |
| SCHEMBL12149348 | 0.84 | MAPT (0.36) | MAPT | |
| SCHEMBL21917319 | 0.84 | PGR (0.31) | PTGDR2 | |
| SCHEMBL23968920 | 0.84 | — | — | |
| SCHEMBL23969037 | 0.82 | MAPT (0.37) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | KDM4E 664/4885MAPT 1908/4885L3MBTL1 3225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.